SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Bayer office in Basel, Switzerland
Layoffs
Bayer to Lay Off 150 in Basel, Switzerland
The Switzerland layoffs are the latest in Bayer’s 2024 workforce reductions, which already include 1,500 people and nearly half of the executive leadership team.
August 26, 2024
 · 
1 min read
 · 
Angela Gabriel
Pictured: Nasdaq building in New York City
IPO
MBX Unveils Plans for Nasdaq Debut, Joins Two Other IPO Hopefuls
MBX Biosciences follows Bicara Therapeutics and Zenas Biopharma, which also announced last week their respective plans to go public in a potential boost to the recent slump in the IPO market.
August 26, 2024
 · 
2 min read
 · 
Tristan Manalac
Illustration of businessman being erased
Layoffs
Tome to Lay Off Almost All of Staff After Scaling Back Operations
Tome Biosciences, a gene editing startup that launched in late 2023 with $213 million in funding, will eliminate 131 positions in November, according to a Worker Adjustment and Retraining Act notice.
August 26, 2024
 · 
2 min read
 · 
Tristan Manalac
Johnson & Johnson's business center in Switzerland
Drug pricing
J&J, HRSA at Loggerheads Over 340B Drug Pricing for Stelara and Xarelto
Johnson & Johnson’s proposed changes to the hospital drug discount program are inconsistent with the federal statute, according to the Health Resources and Services Administration.
August 26, 2024
 · 
2 min read
 · 
Tristan Manalac
A scale and fat cells
Obesity
Deep Dive: Obesity and Diabetes Markets Explode
In this deep dive BioSpace dissects the global obesity and diabetes markets along with the growing pipelines that aim to serve them.
August 26, 2024
 · 
3 min read
 · 
Heather McKenzie
Deals
Biopharma VC Funding in Q2 Reaches Highest Quarterly Level Since 2022
Venture capital in the sector hit $9.2 billion in the second quarter of 2024, up from $7.4 billion in Q1, while exits fell on a slower M&A cycle and picky IPO market.
August 23, 2024
 · 
3 min read
 · 
Kate Goodwin
Patriotic Project 2025 backdrop with American flag and colorful typography. Presidential election concept background
Editorial
Would Trump Repeal the Inflation Reduction Act if Elected?
Project 2025, a blueprint for a potential second Trump term that highlights the IRA as a potential target, took a starring role in this week’s Democratic National Convention.
August 23, 2024
 · 
4 min read
 · 
Greg Slabodkin
Healthcare worker administers a vaccine to a patient
COVID-19
FDA Greenlights Updated COVID-19 Shots from Pfizer, Moderna for Fall Season
The regulator on Thursday said the mRNA vaccines, Pfizer-BioNTech’s Comirnaty and Moderna’s Spikevax, will better protect against currently circulating variants as COVID continues to surge in many parts of the U.S.
August 23, 2024
 · 
2 min read
 · 
Tristan Manalac
3D concept photo of gene editing showing a tweezers inserting a DNA fragment into a larger strand
Gene editing
Gene Editing Startup Tome Struggles to Stay Afloat Just Months After Launching
Despite the promise of its technology and funding from big backers, Tome Biosciences is “operating at reduced capacity” and weighing its “strategic options” as the Massachusetts-based company faces an uncertain future.
August 23, 2024
 · 
2 min read
 · 
Tristan Manalac
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS